Gary Titus Insider Trading
Get free email notifications about insider trading for Gary Titus.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary Titus. Gary Titus is a V.P. and Chief Acctg Officer in ARCA biopharma, Inc. ($ABIO) and a VP Finance, Chief Acct.Officer in ARCA biopharma, Inc. ($ABIO) and a Chairman and Secretary in ImmunoCellular Therapeutics, Ltd. ($IMUC) and a Director in ImmunoCellular Therapeutics, Ltd. ($IMUC).
Address: C/O NUVELO, INC. 675 ALMANOR AVENUE SUNNYVALE 94085 CA
Companies in which Gary Titus is an Insider
ARCA biopharma, Inc.
Trading Symbol: ABIOIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Gary Titus: VP Finance, Chief Acct.Officer, V.P. and Chief Acctg Officer
Holdings: 167 shares
Current Value: $434
Latest Transaction: Aug 03 2005
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunoCellular Therapeutics, Ltd.
Trading Symbol: IMUCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Titus: Chairman and Secretary, Director
Holdings: 28,000 shares
Current Value: $70,840
Latest Transaction: Jun 21 2016
$IMUC Market Capitalization: $8.58M
$IMUC Previous Close: $2.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gary Titus
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2016 | IMUC | ImmunoCellular The ... | Titus Gary | Chairman and Secret ... | Option Exercise | A | 0.24 | 156,750 | 37,620 | 156,750 | |
Sep 22 2015 | IMUC | ImmunoCellular The ... | Titus Gary | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Sep 22 2015 | IMUC | ImmunoCellular The ... | Titus Gary | Director | Grant | A | 0.00 | 10,000 | 0 | 28,000 | 18 K to 28 K (+55.56 %) |
Jun 30 2015 | IMUC | ImmunoCellular The ... | Titus Gary | Director | Option Exercise | A | 0.48 | 75,000 | 36,000 | 75,000 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.16 | 190 | 1,740 | 190 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.16 | 124,810 | 1,143,260 | 124,810 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 6.30 | 167 | 1,052 | 167 | 0 to 167 |